Journal to encourage analysis by sex/ethnicity.
- Published in:
- 2000
- By:
- Publication type:
- commentary
Works matching IS 00278874 AND DT 2000 AND VI 92 AND IP 19
Results: 19
1
2
Consensus meeting to focus on adjuvant therapy for breast cancer.
- Published in:
- 2000
- By:
- Publication type:
- journal article
3
What goes into an NCI best case series?
- Published in:
- 2000
- Publication type:
- journal article
4
Health outcomes after prostatectomy or radiotherapy for prostate cancer: results from the Prostate Cancer Outcomes Study.
- Published in:
- 2000
- By:
- Publication type:
- journal article
5
Surveys identify barriers to participation in clinical trials.
- Published in:
- 2000
- By:
- Publication type:
- journal article
6
Gastric dysplasia and gastric cancer: Helicobacter pylori, serum vitamin C, and other risk factors.
- Published in:
- 2000
- By:
- Publication type:
- journal article
7
Gastric Dysplasia and Gastric Cancer: Helicobacter pylori, Serum Vitamin C, and Other Risk Factors.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2000, v. 92, n. 19, p. 1607, doi. 10.1093/jnci/92.19.1607
- By:
- Publication type:
- Article
8
Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women.
- Published in:
- 2000
- By:
- Publication type:
- journal article
9
Health Outcomes After Prostatectomy or Radiotherapy for Prostate Cancer: Results From the...
- Published in:
- JNCI: Journal of the National Cancer Institute, 2000, v. 92, n. 19, p. 1582, doi. 10.1093/jnci/92.19.1582
- By:
- Publication type:
- Article
10
Immunoconjugates of geldanamycin and anti-HER2 monoclonal antibodies: antiproliferative activity on human breast carcinoma cell lines.
- Published in:
- 2000
- By:
- Publication type:
- journal article
11
Role of the heat shock response and molecular chaperones in oncogenesis and cell death.
- Published in:
- 2000
- By:
- Publication type:
- journal article
12
A model to select chemotherapy regimens for phase III trials for extensive-stage small-cell lung cancer.
- Published in:
- 2000
- By:
- Publication type:
- journal article
13
Gender differences in cancer that don't make sense--or do they?
- Published in:
- 2000
- By:
- Publication type:
- journal article
14
Use of an antibody to target geldanamycin.
- Published in:
- 2000
- By:
- Publication type:
- commentary
15
Surveys Identify Barriers to Participation in Clinical Trials.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2000, v. 92, n. 19, p. 1556, doi. 10.1093/jnci/92.19.1556
- By:
- Publication type:
- Article
16
How does a drug get to phase III trials?
- Published in:
- 2000
- By:
- Publication type:
- journal article
17
Model aims to reduce discrepancy between phase II, phase III trials.
- Published in:
- 2000
- By:
- Publication type:
- commentary
18
Response rates, survival, and chemotherapy trials.
- Published in:
- 2000
- By:
- Publication type:
- commentary
19
Alternative Therapies Getting Notice Through Best Case Series Program.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2000, v. 92, n. 19, p. 1558, doi. 10.1093/jnci/92.19.1558
- By:
- Publication type:
- Article